A new, detailed genetic roadmap of glaucoma – the world’s leading cause of irreversible blindness – will help researchers develop new drugs to combat the disease by identifying potential target areas to stall or reverse vision loss.

Research to determine if vitamin B3 can treat optic nerve damage caused by glaucoma is now recruiting participants.

Coffee and eye research, as well as potential future health screening measures, might not mix.

New research links the appearance of a person’s retina to Parkinson’s and cardiovascular disease risk.

A new start-up company at CERA aiming to develop a gene therapy to ‘switch on sight’ by restoring the retina’s light-sensing cells has won vital funding to accelerate its research.